The Suthanthiran Laboratory's innovative discovery to determine acute rejection in the kidney transplant (by measuring three genes in the urine), and ultimately reducing the need of a kidney transplant biopsy, was selected as one of Top 10 Outstanding Clinical Research Achievements in the U.S. by the Clinical Research Forum.
The 2,800-square-foot-center, located on 70th Street between York and First Avenue, will fill a unique niche, in that it is one of very few dedicated centers in the world addressing one of our country's most pressing health concerns, hypertension.
On the heels of a series of advancements by the Suthanthiran Lab, the team has published a landmark paper in the New England Journal of Medicine (NEJM) showing that a urine biomarker test which they have devised in the lab, can not only diagnose, but predict, rejection of transplanted kidneys.
This was the 22nd annual presentation of the DOM Investigator Award, which is presented to members of the Department of Medicine, below the rank of professor, who perform on an outstanding level in the areas of clinical and/or basic biomedical research. The award is generously supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellows Research Award is presented annually to fellows within the Department of Medicine who have presented outstanding research. This year's winners were announced at the June 11 Medicine Grand Rounds (11th Annual).
Dr. Manikkam Suthanthiran recently attended the first ever Nephrology Conference held in Qatar as guest speaker. The event was covered in The Peninsula, a Qatar newspaper featuring local news with a global vision. Dr. Suthanthiran was quoted in the article on a recent groundbreaking "non-invasive" test for kidney transplant patients that he and his team developed in their laboratory at NYP/WCM.
WCMC investigators, collaborating with national and international scientists, have achieved a milestone in the field of kidney transplantation. For the first time, a human kidney allograft (and/or involving a kidney from a human) has been sequenced for the expression pattern of small RNAs. This original research by Dr. Manikkam Suthanthiran and colleagues has resulted in a landmark paper in Transplantation.
NewYork-Presbyterian Hospital's Division of Nephrology & Hypertension was ranked #3 in the nation out of more than 1600 hospitals evaluated by U.S. News & World Report for its 2012-13 Best Hospitals rankings, which were published on July 16, 2012. This is an upward move from the #5 spot held last year.
Drawing on 30 years of clinical and research experience, Dr. Samuel Mann gives readers information so that they can talk to their physician to be sure they are on the medications that are right for them, with the goals of controlling their hypertension, avoiding side effects, and keeping prescription costs down.
The 2012 Department of Medicine Investigator Award finalists were announced and their talks were delivered during Grand Rounds on May 22, 2012. This was the 21st annual presentation of the DOM Investigator Award, which is presented to members of the Department of Medicine, below the rank of professor, who perform on an outstanding level in the areas of clinical and/or basic biomedical research. The award is generously supported by the Michael Wolk Foundation.
